Showing results (231-240 of 412) with videos related to
Sort By:
Pageof 42
Gynecologic Oncology|July 13, 2010
Up-regulation of stromal versican expression in advanced stage serous ovarian cancerSue Ghosh, Lina Albitar, Richard LeBaron, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patientsF A Jung, A C Buzaid, M I Ross, et al.Blood|November 26, 1999
Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemiaA Aguayo, E Estey, H Kantarjian, et al.Cancer Research|January 19, 1999
ATM mutations in B-cell chronic lymphocytic leukemiaF Bullrich, D Rasio, S Kitada, et al.Leukemia Research|September 23, 2016
Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS)Ellin Berman, Suresh Jhanwar, Cyrus Hedvat, et al.Cancer|March 29, 2002
The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative diseaseFrancesco DiRaimondo, Maher Albitar, Yang Huh, et al.Leukemia Research|December 25, 2007
An immunological method for the detection of BCR-ABL fusion protein and monitoring its activationIman Jilani, Hagop Kantarjian, Homan Faraji, et al.Cancers|February 26, 2025
cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantation for Myeloid MalignanciesScott D Rowley, Maher Albitar, Melissa F Baker, et al.Scandinavian Journal of Urology|March 4, 2026
Plasma and urine biomarker algorithm versus systematic biopsy for prostate cancer detection in elderly men: a randomised trial with early termination for futilityTorben Brøchner Pedersen, Charlotte Aaberg Poulsen, Martin Lund, et al.Blood|June 22, 2001
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemiaS Ibrahim, M Keating, K A Do, et al.Pageof 42